scispace - formally typeset
Z

Zarir F Udwadia

Researcher at P. D. Hinduja Hospital and Medical Research Centre

Publications -  159
Citations -  10522

Zarir F Udwadia is an academic researcher from P. D. Hinduja Hospital and Medical Research Centre. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 35, co-authored 139 publications receiving 8779 citations.

Papers
More filters
Journal ArticleDOI

American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

TL;DR: The Diagnostic Process Is Dynamic Clinical Evaluation Radiological Evaluation Role of Surgical Lung Biopsy Unclassifiable Interstitial Pneumonia Bronchoalveolar Lavage Fluid Evaluation Idiopathic Pulmonary Fibrosis.
Journal ArticleDOI

Totally Drug-Resistant Tuberculosis in India

TL;DR: The first patients from India with TDR tuberculosis are described, and drug susceptibility testing was performed at the Hinduja Hospital, the city's busiest referral laboratory and a Revised National Tuberculosis Control Programme (RNTCP) accredited laboratory.
Journal ArticleDOI

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

TL;DR: Several lines of evidence suggest that alternative mechanisms-including pharmacokinetic variability, induction of efflux pumps that transport the drug out of cells, and suboptimal drug penetration into tuberculosis lesions-are likely crucial to the pathogenesis of drug-resistant tuberculosis.
Journal ArticleDOI

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Nafees Ahmad, +107 more
- 08 Sep 2018 - 
TL;DR: Treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis, and the need for trials to ascertain the optimal combination and duration of these drugs is emphasised.